Lecanemab Reduces Neuropsychiatric Symptoms and Related Regional Brain Amyloid Load in Early Alzheimer's Disease: A Preliminary Prospective Study
CNS Neuroscience & Therapeutics · 2026-06 · 32 (6)
DOI: 10.1002/cns.70974 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 11.06.2026. Verfasst von Yan Chang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, the First Medical Center, Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Brain, Amyloid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Ministry of Science and Technology of the People's Republic of China, Health Special Research Projects.
Themen: Demenz
Abstract (Originalsprache)
Aim
This prospective study examined whether lecanemab was associated with changes in neuropsychiatric symptoms (NPS) and investigated their associations with cerebral amyloid burden in patients with early‐stage Alzheimer's disease (AD).
Methods
Fourteen eligible participants underwent amyloid positron emission tomography, magnetic resonance imaging, and neuropsychological assessments at baseline and following 6 months of lecanemab treatment. Neuropsychological assessments included the Clinical Dementia Rating, Mini‐Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Hamilton Depression Rating Scale, Hamilton Anxiety Scale (HAMA), and Neuropsychiatric Inventory (NPI).
Results
MMSE and MoCA remained stable, while amyloid burden decreased after 6 months of treatment ( p < 0.05). HAMA, total NPI score, and NPI sub‐scores for psychosis, hyperactivity, and apathy were also decreased ( p < 0.05). Improvements in NPS were associated with lower amyloid burden in the hippocampus, amygdala, thalamus, inferior frontal gyrus (IFG), and anterior cingulate gyrus. These clinical improvements were associated with increased fractal dimension in the middle cingulate cortex and decreased sulcal depth in the IFG.
Conclusions
These findings suggest that, in early AD, lecanemab treatment may be associated with benefits beyond cognitive stabilization, including possible improvement in NPS, which may relate to amyloid clearance and structural changes in relevant brain regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
- Senior Department of Neurology, Chinese PLA General Hospital, Beijing, China.
- Graduate School of the Chinese PLA General Hospital, Beijing, China.
- Department of Cadres' Outpatient, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
- Department of Neurology, the Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
- Beijing United Imaging Healthcare, Beijing, China.
ORCID-Profile: Hairong Qian, Ruimin Wang
Förderung
- the National Natural Science Foundation of China
- the Ministry of Science and Technology of the People's Republic of China
- Health Special Research Projects
- Novel Medical Technologies and Innovative Services of Chinese PLA General Hospital
Zitieren
APA
Chang, Y., Li, H., Liu, X., Li, X., Liu, J., Song, J., Fu, H., Xu, X., Wang, Y., Wang, Q., Ren, N., Chen, J., Deng, X., Zhang, X., Zuo, L., Zhou, B., Sun, X., Li, Z., Cao, Y., …, & Wang, R. (2026). Lecanemab Reduces Neuropsychiatric Symptoms and Related Regional Brain Amyloid Load in Early Alzheimer's Disease: A Preliminary Prospective Study. CNS Neuroscience & Therapeutics, 32(6). https://doi.org/10.1002/cns.70974
Vancouver
Chang Y, Li H, Liu X, Li X, Liu J, Song J, et al. Lecanemab Reduces Neuropsychiatric Symptoms and Related Regional Brain Amyloid Load in Early Alzheimer's Disease: A Preliminary Prospective Study. CNS Neuroscience & Therapeutics. 2026;32(6). doi:10.1002/cns.70974
BibTeX
@article{Chang2026,
author = {Chang, Yan and Li, Hua and Liu, Xiaojie and Li, Xuemei and Liu, Jiajin and Song, Jingbin and Fu, Huaping and Xu, Xiaodan and Wang, Yuan and Wang, Qianyao and Ren, Na and Chen, Jilin and Deng, Xin and Zhang, Xue and Zuo, Luofei and Zhou, Bo and Sun, Xuan and Li, Zihan and Cao, Yuanyan and Wu, Runze and Jia, Jianjun and Qian, Hairong and Wang, Ruimin},
title = {Lecanemab Reduces Neuropsychiatric Symptoms and Related Regional Brain Amyloid Load in Early Alzheimer's Disease: A Preliminary Prospective Study},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {6},
doi = {10.1002/cns.70974}
}
EUVIMED